Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders

Overview of attention for article published in BMC Psychiatry, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 1 news story.

Summary Teva's Q1 2023 report reveals mixed results with revenue growth in some products and declines in others.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.